Navigation Links
Therapeutic Proteins to 2016: Drugs, Devices, Diseases, Markets and Forecasts
Date:3/22/2013

DUBLIN, March 22, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Therapeutic Proteins to 2016. Drugs, Devices, Diseases, Markets and Forecasts" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In recent years, the number of protein-based pharmaceuticals reaching the marketplace has increased exponentially. The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution.

It therefore becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively for parenteral administration.

These combination drug-device products, where the drug and device are clinically tested and approved as a single product entity, are becoming one of the fastest new drug categories. The growth of protein drug products is having a significant effect on the way drugs and devices are developed.

Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies.

Highlights:

- Analyzes approved therapeutic protein products and pipeline candidates and assesses the market potential for existing and probable future protein drug

- Examines protein delivery design issues, packaging, distribution and technology factors

- Assesses the role of protein formulation decisions on therapeutic protein commercialization and market potent
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
2. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
3. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
4. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
5. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
6. Echo Therapeutics Achieves ISO 13485 Certification
7. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
8. Echo Therapeutics Appoints Robert Doman to Board of Directors
9. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
10. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
11. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Research and Markets  has announced the addition of ... report to their offering. Intranasal drug delivery ... of drugs for the treatment of local diseases in ... non-allergic rhinitis and sinusitis. The nose is considered to ... systematic drug delivery. Continuous technological advancement ...
(Date:8/26/2014)... , Aug. 26, 2014   Quanta Aesthetic Lasers , ... North America , expands the offerings in their robust ... which is now available for shipping to medical spas, clinics, ... . The QuantaShape is manufactured in the Chianti ... General Project .  The device was previously sold as both ...
(Date:8/26/2014)...  When it comes to diabetes supplies, innovations are often ... happens to answer a real medical need. ... market, Timesulin shows how long it,s been since your ... or double insulin doses. Very easy to use, Timesulin ... insulin pen after an injection. There is no settings ...
Breaking Medicine Technology:Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup 2Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2
... Popular antidepressants taken with tamoxifen can increase the risk ... May 30 A new study found that taking ... of breast cancer recurrence in women taking both medications. ... work effectively.(Logo: http://www.newscom.com/cgi-bin/prnh/20090530/DC24767LOGO ) ...
... Abstract # 25670ORLANDO, Fla., May 29 ... has selected new breast cancer research conducted ... in Detroit for posting on ASCO,s Web ... promising new therapeutic target for aggressive hormone ...
Cached Medicine Technology:New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3
(Date:8/27/2014)... A recent University College London (UCL) ... the dental community disagrees on the best way to ... of dental advice suggested that some six different tooth-brushing ... more popular than the rest. , “The easiest ... floss your teeth regularly,” said Dr. Alexandre-Amir Aalam, DDS, ...
(Date:8/27/2014)... "It can be quite difficult to wipe one’s ... inventor from Lehigh Acres, Fla.," so I designed an ... task." He then created a prototype of his idea. ... to wipe and clean the behind thoroughly after going ... well as prevents direct contact with waste or anal ...
(Date:8/27/2014)... Neil Haley, the Total Tutor host of the ... out about the importance of capacity to grow a business. ... ViSalus and is now a 5 Star Ambassador, Vi Millionaire, ... book titled "The Playful and Powerful Warrior Within You!" and ... working out for over 1000 days straight. He is ...
(Date:8/27/2014)... City, Utah (PRWEB) August 27, 2014 ... advancing the business of healthcare, is pleased to ... a ground-breaking online recruitment resource specifically designed for ... is undergoing significant changes. To help address the ... workforce, and tighter budgets—AAPC launched CareerHealth.com . ...
(Date:8/27/2014)... IntelliSoft Group, LLC, a leading provider of credentialing, ... IntelliCred, IntelliApp and IntelliContract Version 14.2 at ... Annual Conference on September 16, 2014 at the SERESC ... improvements available in IntelliSoft’s Version 14.2 healthcare ... A new Contract Connection Tab connects the healthcare provider ...
Breaking Medicine News(10 mins):Health News:Americans Confused About How to Brush Teeth 2Health News:InventHelp Client's Device Helps a User Wipe Thoroughly After Going to the Bathroom (HLW-1300) 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 3Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2
... pressure as it has been urged to make emergency contraception ... Eschenbach, acting Commissioner of the FDA has been urged to ... to sell its morning after pill or Plan B without ... set of two pills that can prevent pregnancy if taken ...
... arrested for allegedly selling fake question papers of the Combined ... 17 districts in the state today, police said. ... held here for selling CPMT question papers, which later turned ... of K G Dental University, which organised the CPMT examinations ...
... drugs seem to hold many youth under a spell. Recent ... to the tune of an increase of 400%, ever since ... reiterated the need for specialized services to remedy this menace, ... the University of Glasgow, said: "These figures are shocking and ...
... is to be conducted among children in the age group ... the kids are following proper eating habits// and there by ... mainly to tackle the worsening health crisis. But the Children's ... the child’s parents about the test results would stigmatize some ...
... is the second most deadly cancer among women. Statistics reveals ... result of cervical cancer. Hence researchers were keen on finding ... way to the development of a vaccine with the potential ... cervical cancer. ,It is mainly caused by ...
... conducted at New York indicates that people suffering from symptomatic ... C// and manganese than their counterparts without the problem. ... Dr N. J. Wareham et al of Medical Research Council ... reduce the onset of asthma. ,This study revealed ...
Cached Medicine News:
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... Nellcor's most popular handheld oximeter has ... Oximetry platform and is now compatible with ... including the MAX-FAST Forehead Sensor and SoftCare ... Pulse Oximeter also incorporates Nellcor's latest advanced ...
... expanding the growing portfolio of OxiMax® ... is a compact, affordable bedside monitor. ... processing technology, it offers reliable operation ... compatible with the complete family of ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
Medicine Products: